Medication-associated lesions of the GI tract

Jennifer Seminerio, Kevin McGrath, Christina A. Arnold, Lysandra Voltaggio, Aatur D. Singhi

Research output: Contribution to journalArticlepeer-review

Abstract

Medications play an integral role in the health and wellbeing of patients. However, a large number of medications are reported to damage one or more segments of the GI tract, either directly or indirectly, resulting in a variety of clinicopathologic findings. Although some findings are pathognomonic for specific drugs, many more demonstrate nonspecific pathology. Early recognition of GI tract drug-induced injury is critical because the consequences of prolonged use, in some instances, can be fatal. Reducing the incidence of adverse effects requires an appropriate index of suspicion and good communication between the gastroenterologist and pathologist, both of which can significantly impact patient care.

Original languageEnglish (US)
Pages (from-to)140-150
Number of pages11
JournalGastrointestinal endoscopy
Volume79
Issue number1
DOIs
StatePublished - Jan 2014
Externally publishedYes

Keywords

  • COX
  • MMF
  • NSAID
  • cyclooxygenase
  • mycophenolate mofetil
  • nonsteroidal anti-inflammatory drug

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

Fingerprint Dive into the research topics of 'Medication-associated lesions of the GI tract'. Together they form a unique fingerprint.

Cite this